MedPath

Interest of an Adapted Physical Activity (APA) Program Among Patients With Juvenile Idiopathic Arthritis: a Feasibility and Efficacy Preliminary Study

Not Applicable
Recruiting
Conditions
Juvenile Idiopathic Arthritis
Interventions
Other: Adaptated Physical Activity (APA) + pedometer watch
Registration Number
NCT05572424
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

The Juvenile Idiopathic Arthritis (JIA) affects joints mobility and leads pain, impacting the practice of physical activities. Adapted Physical Activities are rehabilitation methods increasingly used, but additional studies are needed to define the nature of the physical activity for patients with JIA. The ATHLETIQUE project aims to evaluate the impact of a program integrating APA sessions together with the wearing of a pedometer watch on disease activity of patients with JIA.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Adaptated Physical Activity + pedometer watchAdaptated Physical Activity (APA) + pedometer watchFollow an Adapted Physical Activity program during 12 weeks and wear a pedometer watch during 1 year
Primary Outcome Measures
NameTimeMethod
Juvenile Arthritis Disease Activity-27 Score AssesmentWeek 14

JADAS-27 score includes 4 components :

1. number of inflammatory joints among 27 joints identified,

2. a medical assesment of clinical disease activity with Visual Analogic Scale (from 0 point = worst to 10 points = best),

3. assesment of assesment of patient's well-being by the patient or a parent with Visual Analogic Scale (froom 0 point = worst to 10 points = best),

4. sedimentation rate (from 0 to 10).

Secondary Outcome Measures
NameTimeMethod
Assessment of the feasibility of the programweek 1 to 50

Assessment of pedometer watch wearing time over the duration of the study.

Juvenile Arthritis Disease Activity-27 Score AssesmentWeeks 26 and 50

JADAS-27 score includes 4 components :

1. number of inflammatory joints among 27 joints identified,

2. a medical assesment of clinical disease activity with Visual Analogic Scale (from 0 point = worst to 10 points = best),

3. assesment of assesment of patient's well-being by the patient or a parent with Visual Analogic Scale (froom 0 point = worst to 10 points = best),

4. sedimentation rate (from 0 to 10).

Quantification of the difference in muscle strengthWeeks 14, 26 and 50

By dynamometry (Newton)

Evaluation of the physical activity levelEach day during 50 weeks

The difference of the medium physical activity level is assessed by the number of steps estimated by the pedometer watch (only for the experimental group).

Pedometric measurements will be performed throughout the study but collected one week per month to determine a monthly value.

Evolution of quality of lifeWeeks 14, 26 and 50

Difference of the score obtained in the Pediatric Quality of Life (PedsQL) tool. Score out of 100 for children assess and 100 for parents assess. A high score means a reduced quality of life.

Evolution of painWeeks 14, 26 and 50

Assessment by the Visual Analogic Scale (VAS) of the CHAQ-38 tool. VAS are out of 10. A high score means an increased pain.

Evolution of functional capacitiesWeeks 14, 26 and 50

Assessment by the questionnaire of the ChildHood Assessment Questionnaire (CHAQ-38) tool. Questionaire's score out of 3, it's a medium of 8 items. A high score means reduced functional capacities.

Evolution of fatigueWeeks 14, 26 and 50

Difference of the score obtained in the PedsQL-Multidimensional Fatigue Scale questionnaire. Score out of 100 for children assess and 100 for parents assess. A high score means a increased fatigue.

Trial Locations

Locations (3)

CHU de Besançon

🇫🇷

Besançon, France

Hôpital Nord Franche-Comté

🇫🇷

Trévenans, France

Hospices Civils de Lyon

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath